NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women

NCT07146139

TerminatedNA

Sponsor: Public Health Foundation Enterprises, Inc.

Conditions: HIV Pre-exposure Prophylaxis, HIV Prevention and Care, Mobile Health Technology (mHealth), Adherence, Doxycycline STI PEP

Interventions: MyPrEP Plus Package, Standard of Care (SOC)

Countries: United States

The primary goal of this randomized controlled trial is to learn if a decision support tool called MyPrEP Plus can help transgender women make decisions about taking pre-exposure prophylaxis (PrEP) for HIV prevention.

Eligibility overview

Sex: MALE

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Are age 18 or older
* Identify as a transgender woman or woman and was assigned male sex at birth
* Are not currently on PrEP in the last three months and interested in learning more about PrEP
* Able to successfully send and receive text messages
* HIV negative by self-report
* Are able to speak, read and write in English or Spanish
* Report any of the following in the last 12 months:

  * Having anal or vaginal sex with a person assigned male at birth
  * Exchange of sex for money, goods, or services
  * Received a diagnosis of a sexually transmitted infection
  * Sharing injection equipment
* Are able and willing to provide written informed consent and participate for the duration of the study

Exclusion Criteria:

* In a mutually monogamous sexual relationship with an HIV-negative partner for the past 12 months
* Of any medical, psychiatric, or social condition that in the opinion of the investigator would preclude participation or their ability to remain in the trial
* Study site staff member

Locations (1)

San Francisco, California, United States